Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
Altered metabolism is a hallmark of cancer. However, the role of genomic changes in metabolic genes driving the tumour metabolic shift remains to be elucidated. Here, we have investigated the genomic and transcriptomic changes underlying this shift across ten different cancer types.A systematic pan-...
المؤلفون الرئيسيون: | Haider, S, McIntyre, A, van Stiphout, R, Winchester, L, Wigfield, S, Harris, A, Buffa, F |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
BioMed Central
2016
|
مواد مشابهة
-
The tumour hypoxia induced non-coding transcriptome.
حسب: Choudhry, H, وآخرون
منشور في: (2016) -
Gene expression signatures as biomarkers of tumour hypoxia
حسب: Harris, B, وآخرون
منشور في: (2015) -
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
حسب: Jubb, A, وآخرون
منشور في: (2010) -
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC)
حسب: Harris, A, وآخرون
منشور في: (2016) -
Metabolic Shift and Hyperosmolarity Underlie Age-Related Macular Degeneration
حسب: Laurent Schwartz, وآخرون
منشور في: (2024-09-01)